Quarantining asymptomatic people who may have Ebola is unnecessary and harmful, according to experts.
Initial safety and efficacy results of VSV-ZEBOV, a second Ebola vaccine candidate, are expected by the end of 2014.
Experts call for more thorough research into the effectiveness of the 21-day surveillance period.
Experts have said that it is unlikely that Texas Health Presbyterian Hospital will see a lawsuit from the first American Ebola victim’s family.
Lessons learned from treating the first known patient with Ebola virus infection in the United States offer a sobering look into the enormous challenge this disease represents.